Remdesivir: McEnany Says Patients Won’t Pay, Hospitals Will Profit from Gilead Drug

Published by : Bloomberg QuickTake News
White House Press Secretary Kayleigh McEnany said that “patients will be very unlikely to see the cost” of Gilead’s remdesivir under the new pricing model and that “hospitals will profit” by releasing patients early. She made the remarks during a press briefing at the White House on Monday, June 29, in Washington, D.C.

Subscribe to our YouTube channel:

Follow QuickTake on Twitter:
Like QuickTake on Facebook:
Follow QuickTake on Instagram:
Subscribe to our newsletter:
Email us at [email protected]

QuickTake by Bloomberg is a global news network delivering up-to-the-minute analysis on the biggest news, trends and ideas for a new generation of leaders.
cached video

florida coronavirus covid testing near me cvs covid testing symptoms of coronavirus california coronavirus us coronavirus cases texas coronavirus coronavirus california free covid testing near me michigan coronavirus ohio coronavirus coronavirus texas coronavirus testing near me cdc coronavirus houston coronavirus symptoms of corona virus los angeles coronavirus remdesivir pennsylvania coronavirus affordable care act coronavirus testing